참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Phosphate | HCID 1061 | — |
| 반응물 | Sodium Chloride | HCID 5234 | — |
| 반응물 | Potassium Hydroxide | HCID 14797 | — |
| 반응물 | Sodium Lauryl Sulfate | HCID 3423265 | — |
| 반응물 | Barium hydroxide | HCID 6093286 | — |
| 반응물 | Gentamicin Sulfate | HCID 9855350 | — |
| 용매 | Water | HCID 962 | — |
| 생성물 | Gentamicin C1 | HCID 72395 | — |
반응 단계
50 mg of gentamicin sulfate in 5 mL of water is neutralized by adding barium hydroxide until no further precipitate is formed. The precipitate, barium sulfate, is removed by centrifugation. The supernatant is added to a mixture of 5 mL of the polystyrene/polyglycidyl methacrylate polymer particle prepared in Example 4 and 5 mL of a 0.1% suspension of "Schercozoline" S (a substituted imidazoline from stearic acid, available from Scher Chemical Co.) at a pH of 8.5 adjusted with potassium hydroxide. The mixture is warmed to 75° C. for approximately 30 min, diluted with 200 mL of water, and deionized using a mixed bed ion exchange resin. 0.4 mL of the resulting particle reagent is added to 20 mL of 0.1% sodium dodecyl sulfate (SDS) followed by the addition of 0.2 mL of 0.020 M phosphate buffer (pH 7.43) containing 0.3 m NaCl and 0.1% SDS.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US04401765 |
|---|
| 출처 데이터셋 | uspto-grants-1983_08 |
|---|
| ORD ID | ord-4cc75235e28f441db68ef87f907cfce9 |
|---|
| 출처 메모 | uspto-grants-1983_08 |
|---|